Psychiatric Disorders and Hydroxychloroquine for Coronavirus Disease 2019 (COVID-19): A VigiBase Study
Philippe Garcia, Alexis Revet, Antoine Yrondi, Vanessa Rousseau, Yannick Degboé, François Montastruc
Topics & Concepts
HydroxychloroquineMedicineAdverse effectLopinavirPharmacovigilancePsychiatryTocilizumabContext (archaeology)Odds ratioInternal medicineCoronavirus disease 2019 (COVID-19)DiseaseInfectious disease (medical specialty)PaleontologyBiologyCOVID-19 Clinical Research StudiesDrug-Induced Ocular ToxicityLong-Term Effects of COVID-19